- Home
- NRDS vs ATRC Comparison
NRDS vs ATRC Comparison
Compare NRDS & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRDS
- ATRC
- Stock Information
- Founded
- NRDS 2009
- ATRC 2000
- Country
- NRDS United States
- ATRC United States
- Employees
- NRDS N/A
- ATRC N/A
- Industry
- NRDS EDP Services
- ATRC Medical/Dental Instruments
- Sector
- NRDS Technology
- ATRC Health Care
- Exchange
- NRDS Nasdaq
- ATRC Nasdaq
- Market Cap
- NRDS 1.0B
- ATRC 1.1B
- IPO Year
- NRDS 2021
- ATRC 2005
- Fundamental
- Price
- NRDS $10.33
- ATRC $38.39
- Analyst Decision
- NRDS Buy
- ATRC Strong Buy
- Analyst Count
- NRDS 5
- ATRC 10
- Target Price
- NRDS $17.60
- ATRC $49.50
- AVG Volume (30 Days)
- NRDS 617.6K
- ATRC 539.4K
- Earning Date
- NRDS 02-19-2025
- ATRC 02-12-2025
- Dividend Yield
- NRDS N/A
- ATRC N/A
- EPS Growth
- NRDS N/A
- ATRC N/A
- EPS
- NRDS 0.38
- ATRC N/A
- Revenue
- NRDS $687,600,000.00
- ATRC $465,307,000.00
- Revenue This Year
- NRDS $14.44
- ATRC $14.41
- Revenue Next Year
- NRDS $13.10
- ATRC $12.87
- P/E Ratio
- NRDS $27.42
- ATRC N/A
- Revenue Growth
- NRDS 14.71
- ATRC 16.55
- 52 Week Low
- NRDS $10.10
- ATRC $18.94
- 52 Week High
- NRDS $17.30
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- NRDS 21.71
- ATRC 47.41
- Support Level
- NRDS $13.25
- ATRC $37.72
- Resistance Level
- NRDS $14.45
- ATRC $42.68
- Average True Range (ATR)
- NRDS 0.75
- ATRC 1.78
- MACD
- NRDS -0.36
- ATRC -0.59
- Stochastic Oscillator
- NRDS 3.38
- ATRC 13.51
About NRDS NerdWallet Inc.
Nerdwallet Inc is a company that provides onsumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. They get revenue from fees paid by its financial services partners in the form of either revenue per action, revenue per click, revenue per lead and revenue per funded loan arrangements.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.